We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

OPGN OpGen Inc

0.0299 (7.47%)
Dec 04 2023 - Closed
Delayed by 15 minutes


Draw Mode:

Volume 409,595
Bid Price 0.43
Ask Price 0.435
News -
Day High 0.46


52 Week Range


Day Low 0.3951
Share Name Share Symbol Market Stock Type
OpGen Inc OPGN NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.0299 7.47% 0.43 17:20:16
Open Price Low Price High Price Close Price Previous Close
0.40 0.3951 0.46 0.437899 0.4001
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
799 409,595 US$ 0.4243796 US$ 173,824 - 0.165 - 9.054
Last Trade Type Quantity Price Currency
17:20:16 formt 2,815 US$ 0.43 USD

OpGen Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
4.41M 10.01M - 2.61M -37.28M -3.72 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

OpGen News

Date Time Source News Article
11/23/202323:15Edgar (US Regulatory)Form EFFECT - Notice of Effectiveness
11/14/202315:30GlobeNewswire Inc.OpGen Reports Third Quarter 2023 Financial Results and..
11/13/202315:59Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of..
11/07/202315:30Edgar (US Regulatory)Form 8-K - Current report
10/26/202315:30Edgar (US Regulatory)Form 8-K - Current report
10/16/202315:30Edgar (US Regulatory)Form 8-K - Current report
10/13/202316:18Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]
10/13/202316:17Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]
10/13/202316:15Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]
10/13/202316:14Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]
10/13/202316:13Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]
10/12/202311:32GlobeNewswire Inc.OpGen Enters Into Warrant Inducement Transaction for up to..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No OPGN Message Board. Create One! See More Posts on OPGN Message Board See More Message Board Posts

Historical OPGN Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.4550.48790.39510.4297342157,563-0.025-5.49%
1 Month0.740.79980.39510.5379589312,076-0.31-41.89%
3 Months0.19953.840.190.68743124,795,7670.2305115.54%
6 Months0.70023.840.1650.6591182,455,969-0.2702-38.59%
1 Year3.1969.0540.1652.392,626,431-2.77-86.55%
3 Years39.0087.400.16532.732,362,540-38.57-98.9%
5 Years22.00256.000.16539.682,063,447-21.57-98.05%

OpGen Description

OpGen Inc is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. It is developing molecular information products and services for healthcare settings, helping to guide clinicians with rapid and actionable information about life-threatening infections, improve patient outcomes, and decrease the spread of infections caused by MDROs. Its proprietary DNA tests and informatics address the rising threat of antibiotic resistance by helping physicians and other healthcare providers optimize care decisions for patients with acute infections. The company's product candidates and services combine its Acuitas molecular diagnostics and Acuitas Lighthouse informatics platform for use with its curated MDRO knowledge base.

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 |